Reading Time: 2 minutes
Hims & Hers (HIMS) demonstrated relative strength with a price performance of nearly 20% in the past trading week and is, for the following reasons, an interesting option for long maneuvers again: Hims & Hers combines AI, telemedicine, and personalized health solutions. I particularly focus on subscriber growth, which recently increased by 19% to 2.9 million, thereby building a large, continuous data treasure. The second quarter delivered a revenue increase of 38%. Although losses were significantly higher than anticipated, profitability...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
